{"entity":{"type":"insider","cik":"0001873394","url":"/insider/0001873394","json_url":"/insider/0001873394.json","name":"Sethuraman Natarajan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":10,"first":"2023-04-19","last":"2026-05-04","span_basis":"filed_date"},"name_variants":[{"name":"Sethuraman Natarajan","source":"filing","n_filings":10,"first_seen":"2023-04-19","last_seen":"2026-05-04"}],"transactions":[{"id":5866015,"accession":"0001873394-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001873394-26-000003","line_url":"/filing/0001873394-26-000003#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (President, Research & Develop)","officer_title":"President, Research & Develop.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25907.0,"shares_display":"25,907","price_per_share":15.3939,"price_display":"15.39","price_state":"stated","total_value":398809.7673,"total_display":"398,809.77","shares_owned_after":216317.0,"shares_owned_after_display":"216,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-04","scope":"insider"},{"id":3138579,"accession":"0001689375-24-000067","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-24-000067","line_url":"/filing/0001689375-24-000067#line-3","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (President, Research & Develop)","officer_title":"President, Research & Develop.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11703.0,"shares_display":"11,703","price_per_share":20.1475,"price_display":"20.15","price_state":"stated","total_value":235786.1925,"total_display":"235,786.19","shares_owned_after":144997.0,"shares_owned_after_display":"144,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-03","filed_date":"2024-12-03","scope":"insider"},{"id":3138575,"accession":"0001689375-24-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-24-000067","line_url":"/filing/0001689375-24-000067#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (President, Research & Develop)","officer_title":"President, Research & Develop.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4088.0,"shares_display":"4,088","price_per_share":20.2626,"price_display":"20.26","price_state":"stated","total_value":82833.5088,"total_display":"82,833.51","shares_owned_after":156700.0,"shares_owned_after_display":"156,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-03","scope":"insider"},{"id":3138569,"accession":"0001689375-24-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000067","line_url":"/filing/0001689375-24-000067#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (President, Research & Develop)","officer_title":"President, Research & Develop.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","shares_owned_after":160788.0,"shares_owned_after_display":"160,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-29","filed_date":"2024-12-03","scope":"insider"},{"id":2195513,"accession":"0001689375-24-000066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-24-000066","line_url":"/filing/0001689375-24-000066#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (President, Research & Develop)","officer_title":"President, Research & Develop.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":20.0403,"price_display":"20.04","price_state":"stated","total_value":54108.81,"total_display":"54,108.81","shares_owned_after":160888.0,"shares_owned_after_display":"160,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-13","filed_date":"2024-11-13","scope":"insider"},{"id":2195510,"accession":"0001689375-24-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000066","line_url":"/filing/0001689375-24-000066#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (President, Research & Develop)","officer_title":"President, Research & Develop.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1409.0,"shares_display":"1,409","price_per_share":20.0079,"price_display":"20.01","price_state":"stated","total_value":28191.1311,"total_display":"28,191.13","shares_owned_after":163588.0,"shares_owned_after_display":"163,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":2098345,"accession":"0001689375-24-000064","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001689375-24-000064","line_url":"/filing/0001689375-24-000064#line-4","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (President, Research & Develop)","officer_title":"President, Research & Develop.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9554.0,"shares_display":"9,554","price_per_share":18.7097,"price_display":"18.71","price_state":"stated","total_value":178752.4738,"total_display":"178,752.47","shares_owned_after":167742.0,"shares_owned_after_display":"167,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-06","scope":"insider"},{"id":2098342,"accession":"0001689375-24-000064","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-24-000064","line_url":"/filing/0001689375-24-000064#line-3","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (President, Research & Develop)","officer_title":"President, Research & Develop.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2745.0,"shares_display":"2,745","price_per_share":19.3164,"price_display":"19.32","price_state":"stated","total_value":53023.518,"total_display":"53,023.52","shares_owned_after":164997.0,"shares_owned_after_display":"164,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-06","scope":"insider"},{"id":2098339,"accession":"0001689375-24-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-24-000064","line_url":"/filing/0001689375-24-000064#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (President, Research & Develop)","officer_title":"President, Research & Develop.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5171.0,"shares_display":"5,171","price_per_share":18.1795,"price_display":"18.18","price_state":"stated","total_value":94006.1945,"total_display":"94,006.19","shares_owned_after":177296.0,"shares_owned_after_display":"177,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-05","filed_date":"2024-11-06","scope":"insider"},{"id":2098338,"accession":"0001689375-24-000064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000064","line_url":"/filing/0001689375-24-000064#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (President, Research & Develop)","officer_title":"President, Research & Develop.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":749.0,"shares_display":"749","price_per_share":18.022,"price_display":"18.02","price_state":"stated","total_value":13498.478,"total_display":"13,498.48","shares_owned_after":182467.0,"shares_owned_after_display":"182,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-04","filed_date":"2024-11-06","scope":"insider"},{"id":2872770,"accession":"0001689375-24-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000057","line_url":"/filing/0001689375-24-000057#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (President, Research & Develop)","officer_title":"President, Research & Develop.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":10800.0,"total_display":"10,800.00","shares_owned_after":183216.0,"shares_owned_after_display":"183,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":2971660,"accession":"0001689375-24-000053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-24-000053","line_url":"/filing/0001689375-24-000053#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2642.0,"shares_display":"2,642","price_per_share":15.0879,"price_display":"15.09","price_state":"stated","total_value":39862.2318,"total_display":"39,862.23","shares_owned_after":183816.0,"shares_owned_after_display":"183,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-10","scope":"insider"},{"id":2971657,"accession":"0001689375-24-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000053","line_url":"/filing/0001689375-24-000053#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":15.2356,"price_display":"15.24","price_state":"stated","total_value":9141.36,"total_display":"9,141.36","shares_owned_after":186458.0,"shares_owned_after_display":"186,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-06","filed_date":"2024-09-10","scope":"insider"},{"id":2406374,"accession":"0001689375-24-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-24-000041","line_url":"/filing/0001689375-24-000041#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":638.0,"shares_display":"638","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":11484.0,"total_display":"11,484.00","shares_owned_after":188814.0,"shares_owned_after_display":"188,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-07-16","scope":"insider"},{"id":2406372,"accession":"0001689375-24-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000041","line_url":"/filing/0001689375-24-000041#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":10800.0,"total_display":"10,800.00","shares_owned_after":189452.0,"shares_owned_after_display":"189,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-12","filed_date":"2024-07-16","scope":"insider"},{"id":2195507,"accession":"0001689375-24-000031","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001689375-24-000031","line_url":"/filing/0001689375-24-000031#line-3","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9675.0,"shares_display":"9,675","price_per_share":15.188,"price_display":"15.19","price_state":"stated","total_value":146943.9,"total_display":"146,943.90","shares_owned_after":190052.0,"shares_owned_after_display":"190,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-20","scope":"insider"},{"id":2195504,"accession":"0001689375-24-000031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-24-000031","line_url":"/filing/0001689375-24-000031#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8305.0,"shares_display":"8,305","price_per_share":15.1416,"price_display":"15.14","price_state":"stated","total_value":125750.988,"total_display":"125,750.99","shares_owned_after":199727.0,"shares_owned_after_display":"199,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-20","scope":"insider"},{"id":2195500,"accession":"0001689375-24-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-24-000031","line_url":"/filing/0001689375-24-000031#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","shares_owned_after":208032.0,"shares_owned_after_display":"208,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":7952827,"accession":"0001689375-23-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001689375-23-000046","line_url":"/filing/0001689375-23-000046#line-2","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14852.0,"shares_display":"14,852","price_per_share":18.039,"price_display":"18.04","price_state":"stated","total_value":267915.228,"total_display":"267,915.23","shares_owned_after":153447.0,"shares_owned_after_display":"153,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-12","scope":"insider"},{"id":7952824,"accession":"0001689375-23-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000046","line_url":"/filing/0001689375-23-000046#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3026.0,"shares_display":"3,026","price_per_share":18.002,"price_display":"18.00","price_state":"stated","total_value":54474.052,"total_display":"54,474.05","shares_owned_after":168299.0,"shares_owned_after_display":"168,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-12","scope":"insider"},{"id":8089270,"accession":"0001689375-23-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001689375-23-000031","line_url":"/filing/0001689375-23-000031#line-1","is_derivative":false,"issuer_cik":"0001689375","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001689375","owner_cik":"0001873394","owner_name":"Sethuraman Natarajan","owner_url":"/insider/0001873394","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3961.0,"shares_display":"3,961","price_per_share":18.0045,"price_display":"18.00","price_state":"stated","total_value":71315.8245,"total_display":"71,315.82","shares_owned_after":171325.0,"shares_owned_after_display":"171,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-19","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001689375","name":"Entrada Therapeutics, Inc.","url":"/issuer/0001689375","role":"Officer (President, Research & Develop)","n_filings":10,"first_seen":"2023-04-19","last_seen":"2026-05-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001873394","retrieved_at":"2026-08-21T14:50:41+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}